GUARDIAN Trial of Tight Versus Routine Blood Pressure Control During Major Non-Cardiac Surgery to Prevent Serious Cardiovascular and Kidney Complications
Led by The University of Texas Health Science Center, Houston · Updated on 2025-08-29
6254
Participants Needed
20
Research Sites
16 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether tightly controlling blood pressure during major non-cardiac surgery can reduce serious complications related to poor blood flow, such as heart injury, stroke, kidney damage, infections, sepsis, and death within 30 days after surgery. This international randomized trial compares two approaches to managing blood pressure during surgery to see which might better prevent these serious events. The study involves adults aged 45 and older undergoing major surgeries expected to last at least two hours and requiring general or neuraxial anesthesia.
Participants are randomly assigned to one of two groups tight blood pressure management or routine blood pressure management. In the tight management group, medications norepinephrine or phenylephrine are infused to keep the mean arterial pressure MAP at or above 85 mmHg during surgery, and certain blood pressure medications are withheld on the morning of surgery. In the routine management group, blood pressure is managed as usual, with blood pressure medications allowed if the anesthesiologist agrees. Other aspects of anesthesia and postoperative care are handled per standard procedures and clinician judgment in both groups.
During the study, participants will be monitored closely through blood pressure measurements and clinical assessments. Researchers will track the occurrence of major perfusion-related complications in the first 30 days after surgery as the primary outcome. They will also assess postoperative delirium during the first four days after surgery. The study includes detailed anesthesia management and hospitalization, aiming to capture important health outcomes while ensuring patient safety. Participation lasts through the initial postoperative period with ongoing monitoring as needed.
CONDITIONS
Brief Title
The GUARDIAN Trial
Research Team
V
Valerie L. Anderson, BS
D
Daniel Sessler, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
The University of Texas Health Science Center, Houston
Lead Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Tight MAP ≥ 85 mmHg
Routine MAP management
Usual care MAP ≥ 60‑65 mmHg
What it is
Protocolized use of norepinephrine or phenylephrine infusion to keep MAP at or above 85 mmHg during surgery
Intraoperative blood pressure managed per usual clinical routines including morning ACEI/ARB or calcium channel blockers and routine care
Guidelines typically advise maintaining MAP at or above 60–65 mmHg to reduce risk of organ injury
Role in the trial
Investigational strategy under study
Control arm reflecting routine blood pressure management
Represents common non‑study practice
Primary use
To evaluate if tighter intraoperative blood pressure control reduces postoperative complications
To represent standard intraoperative management during study
Reflects common intraoperative blood pressure target outside trial protocols
How it is given or performed
Continuous vasopressor infusion (norepinephrine or phenylephrine) titrated to maintain MAP ≥85 mmHg
Usual anesthesia protocol applied, with medications given as deemed appropriate by anesthesiologist
Blood pressure commonly managed to achieve MAP ≥60–65 mmHg per standard guidelines
Evidence status
Under investigation; no results posted yet
Represents usual care without evidence of superiority
Supported by guidelines and observational associations with reduced organ injury risk
Important risks
Potential for hypertension‑related complications such as increased bleeding or myocardial stress
Reflects risks inherent in routine anesthetic care
Low blood pressure increases organ injury risk; hypotension avoidance reduces this risk
Important limitations
Effectiveness versus routine care is unknown; potential blood pressure overshoot risks
Use of medications based on clinician judgment may vary and reduce consistency
Guideline‑based targets not proven superior in randomized trials for reducing complications
Patient impact
Not yet known; trial is ongoing
Represents current standard practice; risks and benefits similar to usual care
Maintaining MAP ≥60 mmHg is associated with lower organ injury risk in observational studies
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 45Years +
All Genders
Eligibility Criteria
You may qualify if you...
At least 45 years old
Scheduled for major noncardiac surgery expected to last at least 2 hours
Receiving general anesthesia, neuraxial anesthesia, or both
Expected to require at least overnight hospitalization (planned ICU admission acceptable)
Designated ASA physical status 2-4 indicating mild to severe systemic disease
Expected to have direct intraoperative blood pressure monitoring with an arterial catheter
Cared for by clinicians willing to follow the GUARDIAN protocol
Have at least one risk factor: age over 65, peripheral arterial disease, coronary artery disease, stroke or transient ischemic attack, elevated serum creatinine within 6 months, diabetes requiring medication, current or significant smoking history, scheduled for major vascular surgery, body mass index 35 kg/m2 or higher, elevated high-sensitivity troponin T or equivalent within 6 months, or elevated B-type natriuretic protein within 6 months
Have conditions preventing routine or tight blood pressure management such as surgeon request for relative hypotension
Require beach-chair positioning
Have documented history of dementia
Have language, vision, or hearing impairments that may interfere with cognitive assessments
Have contraindications to norepinephrine or phenylephrine as judged by clinicians
Have previously participated in the GUARDIAN trial
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Duration of surgery and immediate perioperative period
Participants undergo major noncardiac surgery with either tight intraoperative blood pressure management using vasopressor infusion to maintain MAP ≥85 mmHg, or routine intraoperative blood pressure management per clinical practice.
1 surgical visit (in-person)
Post-operative Follow-up
Duration - Up to 30 days after surgery
Participants are monitored for complications including delirium and cardiovascular, renal, and cognitive outcomes after surgery.
Approximately 4 to 6 visits during initial 30 days post-surgery
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
PhytoRx Families Pilot Study to Improve Food Security and Increase Fruit and Vegetable Intake in Rural North Carolina
Registry Study on Controlling Ambulatory Blood Pressure in 10,000 Hypertension Patients Using 24-Hour Monitoring
Adapting and Testing a Stress Management Program to Lower Cardiovascular Risk in Women Living With HIV
Evaluating Perfusion Index to Predict Blood Pressure Changes in Adults With Spinal Cord Injury During a Controlled Cool Temperature Challenge
Observational Study to Validate the Wrist-Worn Aktiia Optical Blood Pressure Monitor Compared to Upper Arm Measurements
Study of Blood Pressure and Risk of Cognitive Problems After Stroke in Adults Aged 18 to 90
Study of Inpatient Blood Pressure Levels and Their Link to Hospital Outcomes APPLE Study
Development and Evaluation of an Automated Algorithm for Non-Invasive Blood Pressure Monitoring Using SpO2 Data
Effects of Ketorolac on Vein Size and Nerve Activity During Venous Distension in Adults Aged 21 to 35
Study of Blood Pressure Regulation in Women with Premature, Early, or Typical-Age Menopause Aged 35 to 70
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Intraoperative hypotension is associated with decreased long-term survival in older patients after major noncardiac surgery: Secondary analysis of three randomized trials.